1. 119P Final results of phase II trial (MIRACULUM) of the novel PD-1 inhibitor prolgolimab in patients with advanced melanoma. (15th December 2019) Authors: Tjulandin, S; Fedyanin, M; Demidov, L; Moiseyenko, V; Protsenko, S; Odintsova, S; Semiglazova, T Y; Zukov, R; Lazarev, S; Andreev, A; Nechaeva, M; Makarova, J; Fadeeva, N; Tarasova, A; Kozlova, O; Shustova, M; Garipov, A; Ivanov, R Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LBA6Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC. (17th December 2018) Authors: Rizvi, N A; Chul Cho, B; Reinmuth, N; Lee, K H; Ahn, M-J; Luft, A; van den Heuvel, M; Cobo, M; Smolin, A; Vicente, D; Moiseyenko, V; Antonia, S J; Le Moulec, S; Robinet, G; Natale, R; Nakagawa, K; Zhao, L; Stockman, P K; Chand, V; Peters, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗